← Open Payments lookup

GIANG NGUYEN: Open Payments

NPI 1982097929 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$793 in 30 payments from 9 companies in 2025. Trend: 2023 $396 · 2024 $604 · 2025 $793

Food & beverage: $793
CompanyPaymentsAmount
Novo Nordisk Inc16$354
AstraZeneca Pharmaceuticals LP4$164
Phathom Pharmaceuticals, Inc.1$112
ABBVIE INC.4$68
Dexcom, Inc.1$24
GlaxoSmithKline, LLC.1$23
Amgen Inc.1$17
Lilly USA, LLC1$15
PFIZER INC.1$15

Products named: VOQUEZNA, AIRSUPRA, Rybelsus, Ozempic, QULIPTA, BREZTRI, FARXIGA, Dexcom G6 Transmitter.

Industry payments across TX — which companies pay providers there.